Biomarkers in inflammatory bowel disease: a practical guide
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn’s disease (CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing prevalence now approaching 1% in the Western world. Endoscopic assessment of IBD remains the gold standard for dia...
| 出版年: | Therapeutic Advances in Gastroenterology |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
SAGE Publishing
2024-05-01
|
| オンライン・アクセス: | https://doi.org/10.1177/17562848241251600 |
